Skip to main content
Erschienen in: World Journal of Surgery 7/2012

01.07.2012

United States Trends in the Surgical Treatment of Primary Breast Cancer

verfasst von: Todd M. Tuttle, Natasha M. Rueth, Andrea Abbott, Beth A. Virnig

Erschienen in: World Journal of Surgery | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Excerpt

Before the publication of National Surgical Adjuvant Breast Project Trial (NSABP) B-06, most breast cancer patients in the United States were treated with mastectomy [1, 2]. After the publication of NSABP-B06 in 1985, the rates of breast-conserving surgery (BCS) increased, but only slightly. After the 1990 National Institutes of Health Consensus Statement concluded that BCS plus radiation therapy (RT) was “preferred” for early-stage breast cancer, BCS rates markedly increased throughout the 1990s and early 2000s [2, 3]. However, during the past decade, several trends in the local treatment of breast cancer have been observed that are counter-intuitive to the findings from prospective randomized trials. …
Literatur
1.
Zurück zum Zitat Fisher B, Bauer M, Margolese R et al (1985) Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312:665–673PubMedCrossRef Fisher B, Bauer M, Margolese R et al (1985) Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312:665–673PubMedCrossRef
2.
Zurück zum Zitat Lazovich D, Solomon CC, Thomas DB et al (2000) Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 86:628–637CrossRef Lazovich D, Solomon CC, Thomas DB et al (2000) Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 86:628–637CrossRef
3.
Zurück zum Zitat National Institutes of Health consensus conference (1991) Treatment of early-stage breast cancer. JAMA 265:391–395CrossRef National Institutes of Health consensus conference (1991) Treatment of early-stage breast cancer. JAMA 265:391–395CrossRef
4.
Zurück zum Zitat McGuire KP, Santillan AA, Kaur P et al (2009) Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5,685 patients. Ann Surg Oncol 16:2682–2690PubMedCrossRef McGuire KP, Santillan AA, Kaur P et al (2009) Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5,685 patients. Ann Surg Oncol 16:2682–2690PubMedCrossRef
5.
Zurück zum Zitat Katipamula R, Degnim AC, Hoskin T et al (2009) Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 27:4082–4088PubMedCrossRef Katipamula R, Degnim AC, Hoskin T et al (2009) Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 27:4082–4088PubMedCrossRef
6.
Zurück zum Zitat Morrow M (2009) More mastectomies: is this what patients really want? J Clin Oncol 27:4038–4040PubMedCrossRef Morrow M (2009) More mastectomies: is this what patients really want? J Clin Oncol 27:4038–4040PubMedCrossRef
7.
Zurück zum Zitat Balch CM, Jacobs LK (2009) Mastectomies on the rise for breast cancer: the tide is changing. Ann Surg Oncol 16:2669–2672PubMedCrossRef Balch CM, Jacobs LK (2009) Mastectomies on the rise for breast cancer: the tide is changing. Ann Surg Oncol 16:2669–2672PubMedCrossRef
8.
Zurück zum Zitat Habermann EB, Abbott A, Parsons HM et al (2010) Are mastectomy rates really increasing in the United States? J Clin Oncol 28:3437–3441PubMedCrossRef Habermann EB, Abbott A, Parsons HM et al (2010) Are mastectomy rates really increasing in the United States? J Clin Oncol 28:3437–3441PubMedCrossRef
9.
Zurück zum Zitat Nattinger AB, Gottlieb MS, Veum J et al (1992) Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 326:1102–1107PubMedCrossRef Nattinger AB, Gottlieb MS, Veum J et al (1992) Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 326:1102–1107PubMedCrossRef
10.
Zurück zum Zitat Al-Refaie W, Kuerer HM, Khuwaja A et al (2005) Determinants of mastectomy in breast conservation therapy candidates. Am J Surg 190:602–605PubMedCrossRef Al-Refaie W, Kuerer HM, Khuwaja A et al (2005) Determinants of mastectomy in breast conservation therapy candidates. Am J Surg 190:602–605PubMedCrossRef
11.
Zurück zum Zitat Hershman DL, Buono D, Jacobson J et al (2009) Surgeon characteristics and use of breast conservation surgery in women with early stage breast cancer. Ann Surg 249:828–833PubMedCrossRef Hershman DL, Buono D, Jacobson J et al (2009) Surgeon characteristics and use of breast conservation surgery in women with early stage breast cancer. Ann Surg 249:828–833PubMedCrossRef
12.
Zurück zum Zitat Gilligan MA, Kneusel RT, Hoffmann RG et al (2002) Persistent differences in sociodemographic determinants of breast conserving treatment despite overall increased adoption. Med Care 40:181–189PubMedCrossRef Gilligan MA, Kneusel RT, Hoffmann RG et al (2002) Persistent differences in sociodemographic determinants of breast conserving treatment despite overall increased adoption. Med Care 40:181–189PubMedCrossRef
13.
Zurück zum Zitat Hawley ST, Griggs JJ, Hamilton AS et al (2009) Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients. J Natl Cancer Inst 101:1337–1347PubMedCrossRef Hawley ST, Griggs JJ, Hamilton AS et al (2009) Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients. J Natl Cancer Inst 101:1337–1347PubMedCrossRef
14.
Zurück zum Zitat Tuttle TM, Habermann EB, Grund EH et al (2007) Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 25:5203–5209PubMedCrossRef Tuttle TM, Habermann EB, Grund EH et al (2007) Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 25:5203–5209PubMedCrossRef
15.
Zurück zum Zitat Tuttle TM, Jarosek S, Habermann EB et al (2009) Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 27:1362–1367PubMedCrossRef Tuttle TM, Jarosek S, Habermann EB et al (2009) Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 27:1362–1367PubMedCrossRef
16.
Zurück zum Zitat McLaughlin CC, Lillquist PP, Edge SB (2005) Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005. Cancer 115:5404–5412CrossRef McLaughlin CC, Lillquist PP, Edge SB (2005) Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005. Cancer 115:5404–5412CrossRef
17.
Zurück zum Zitat Sobero ME, Dick AW, Beckjord EB et al (2009) Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol 16:1597–1605CrossRef Sobero ME, Dick AW, Beckjord EB et al (2009) Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol 16:1597–1605CrossRef
18.
Zurück zum Zitat Jones NB, Wilson J, Kotur L et al (2009) Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol 16:2691–2696PubMedCrossRef Jones NB, Wilson J, Kotur L et al (2009) Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol 16:2691–2696PubMedCrossRef
19.
Zurück zum Zitat Metcalfe KA, Lubinski J, Ghadirian P et al (2008) Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. J Clin Oncol 26:1093–1097PubMedCrossRef Metcalfe KA, Lubinski J, Ghadirian P et al (2008) Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. J Clin Oncol 26:1093–1097PubMedCrossRef
20.
Zurück zum Zitat Arrington AK, Jarosek SL, Virnig BA et al (2009) Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol 16:2697–2704PubMedCrossRef Arrington AK, Jarosek SL, Virnig BA et al (2009) Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol 16:2697–2704PubMedCrossRef
21.
Zurück zum Zitat Abbott A, Rueth N, Pappas-Varco S et al (2011) Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol 18:3129–3136PubMedCrossRef Abbott A, Rueth N, Pappas-Varco S et al (2011) Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol 18:3129–3136PubMedCrossRef
22.
Zurück zum Zitat Black WC, Nease RF Jr, Tosteson AN (1995) Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 87:720–731PubMedCrossRef Black WC, Nease RF Jr, Tosteson AN (1995) Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 87:720–731PubMedCrossRef
23.
Zurück zum Zitat Alexander NE, Ross J, Sumner W et al (1996) The effect of an educational intervention on the perceived risk of breast cancer. J Gen Intern Med 11:92–97PubMedCrossRef Alexander NE, Ross J, Sumner W et al (1996) The effect of an educational intervention on the perceived risk of breast cancer. J Gen Intern Med 11:92–97PubMedCrossRef
24.
Zurück zum Zitat Partridge A, Adloff K, Blood E et al (2008) Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst 100:243–251PubMedCrossRef Partridge A, Adloff K, Blood E et al (2008) Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst 100:243–251PubMedCrossRef
25.
Zurück zum Zitat Rakovitch E, Franssen E, Kim J et al (2003) A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat 77:285–293PubMedCrossRef Rakovitch E, Franssen E, Kim J et al (2003) A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat 77:285–293PubMedCrossRef
26.
Zurück zum Zitat Frost MH, Schaid DJ, Sellers TA et al (2000) Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284:319–324PubMedCrossRef Frost MH, Schaid DJ, Sellers TA et al (2000) Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284:319–324PubMedCrossRef
27.
Zurück zum Zitat Montgomery LL, Tran KN, Heelen MC et al (1999) Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol 6:546–552PubMedCrossRef Montgomery LL, Tran KN, Heelen MC et al (1999) Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol 6:546–552PubMedCrossRef
28.
Zurück zum Zitat Geiger AM, Nekhlyudov L, Herrinton LJ et al (2007) Quality of life after bilateral prophylactic mastectomy. Ann Surg Oncol 14:686–694PubMedCrossRef Geiger AM, Nekhlyudov L, Herrinton LJ et al (2007) Quality of life after bilateral prophylactic mastectomy. Ann Surg Oncol 14:686–694PubMedCrossRef
29.
Zurück zum Zitat Altschuler A, Nekhlyudov L, Rolnick SJ et al (2008) Positive, negative, and disparate: women’s differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J 14:25–32PubMedCrossRef Altschuler A, Nekhlyudov L, Rolnick SJ et al (2008) Positive, negative, and disparate: women’s differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J 14:25–32PubMedCrossRef
30.
Zurück zum Zitat Herrinton LJ, Barlow WE, Yu O et al (2005) Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 23:4275–4286PubMedCrossRef Herrinton LJ, Barlow WE, Yu O et al (2005) Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 23:4275–4286PubMedCrossRef
31.
Zurück zum Zitat Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRef Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRef
32.
Zurück zum Zitat Veronesi U, Saccozzi R, Del Vecchio M et al (1981) Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 305:6–11PubMedCrossRef Veronesi U, Saccozzi R, Del Vecchio M et al (1981) Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 305:6–11PubMedCrossRef
33.
Zurück zum Zitat Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106 Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106
34.
Zurück zum Zitat Freedman RA, He Y, Winer EP et al (2009) Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol 27:713–719PubMedCrossRef Freedman RA, He Y, Winer EP et al (2009) Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol 27:713–719PubMedCrossRef
35.
Zurück zum Zitat Malin JL, Kahn KL, Adams J et al (2002) Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst 94:835–844PubMedCrossRef Malin JL, Kahn KL, Adams J et al (2002) Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst 94:835–844PubMedCrossRef
36.
Zurück zum Zitat Daroui P, Gabel M, Khan AJ et al (2011) Utilization of breast conserving therapy in stages 0, I, and II breast cancer patients in New Jersey: an American College of Surgeons National Cancer Data Base (NCDB) analysis. Am J Clin Oncol. doi:10.1097/COC.0b013e318209aa57 Daroui P, Gabel M, Khan AJ et al (2011) Utilization of breast conserving therapy in stages 0, I, and II breast cancer patients in New Jersey: an American College of Surgeons National Cancer Data Base (NCDB) analysis. Am J Clin Oncol. doi:10.​1097/​COC.​0b013e318209aa57​
37.
Zurück zum Zitat Hughes KS, Schnaper LA, Berry D et al (2004) Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351:971–977PubMedCrossRef Hughes KS, Schnaper LA, Berry D et al (2004) Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351:971–977PubMedCrossRef
38.
Zurück zum Zitat Tuttle TM, Jarosek S, Habermann EB et al. (2011) Omission of radiation therapy after breast-conserving surgery in the United States: a population-based analysis of clinicopathologic factors. Cancer. doi:10.1002/cncr.26505 Tuttle TM, Jarosek S, Habermann EB et al. (2011) Omission of radiation therapy after breast-conserving surgery in the United States: a population-based analysis of clinicopathologic factors. Cancer. doi:10.​1002/​cncr.​26505
39.
Zurück zum Zitat Nattinger AB, Kneusel RT, Hoffmann RG et al (2001) Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst 93:1344–1346PubMedCrossRef Nattinger AB, Kneusel RT, Hoffmann RG et al (2001) Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst 93:1344–1346PubMedCrossRef
40.
Zurück zum Zitat Abbott AM, Habermann EB, Tuttle TM (2011) Trends in the use of implantable accelerated partial breast irradiation therapy for early stage breast cancer in the United States. Cancer 117:3305–3310PubMedCrossRef Abbott AM, Habermann EB, Tuttle TM (2011) Trends in the use of implantable accelerated partial breast irradiation therapy for early stage breast cancer in the United States. Cancer 117:3305–3310PubMedCrossRef
42.
Zurück zum Zitat Gao X, Fisher SG, Emami B (2003) Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 56:1038–1045PubMedCrossRef Gao X, Fisher SG, Emami B (2003) Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 56:1038–1045PubMedCrossRef
43.
Zurück zum Zitat Nichols HB, de González AB, Lacey JV Jr et al (2011) Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol 29:1564–1569PubMedCrossRef Nichols HB, de González AB, Lacey JV Jr et al (2011) Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol 29:1564–1569PubMedCrossRef
44.
Zurück zum Zitat Lostumbo L, Carbine N, Wallace J et al (2004) Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev (4):CD002748 Lostumbo L, Carbine N, Wallace J et al (2004) Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev (4):CD002748
45.
Zurück zum Zitat Peele PB, Siminoff LA, Xu Y et al (2005) Decreased use of adjuvant breast cancer therapy in a randomized controlled trial of a decision aid with individualized risk information. Med Decis Making 25:301–307PubMedCrossRef Peele PB, Siminoff LA, Xu Y et al (2005) Decreased use of adjuvant breast cancer therapy in a randomized controlled trial of a decision aid with individualized risk information. Med Decis Making 25:301–307PubMedCrossRef
46.
Zurück zum Zitat Sanghani M, Truong PT, Raad RA et al (2010) Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy. J Clin Oncol 28:718–722PubMedCrossRef Sanghani M, Truong PT, Raad RA et al (2010) Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy. J Clin Oncol 28:718–722PubMedCrossRef
47.
Zurück zum Zitat Bickell NA, Shastri K, Fei K et al (2008) A tracking and feedback registry to reduce racial disparities in breast cancer care. J Natl Cancer Inst 100:1717–1723PubMedCrossRef Bickell NA, Shastri K, Fei K et al (2008) A tracking and feedback registry to reduce racial disparities in breast cancer care. J Natl Cancer Inst 100:1717–1723PubMedCrossRef
48.
Zurück zum Zitat Whelan TJ, Pignol JP, Levine MN et al (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362:513–520PubMedCrossRef Whelan TJ, Pignol JP, Levine MN et al (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362:513–520PubMedCrossRef
Metadaten
Titel
United States Trends in the Surgical Treatment of Primary Breast Cancer
verfasst von
Todd M. Tuttle
Natasha M. Rueth
Andrea Abbott
Beth A. Virnig
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 7/2012
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-012-1469-4

Weitere Artikel der Ausgabe 7/2012

World Journal of Surgery 7/2012 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.